ZHANG Yanli, TANG Qiaohong, WANG Quan, WANG Hao, YANG Chenxu, LI Shu, MENG Xiangfeng
Objective To analyze the registration data of medical robot products in China, clarify the current development status and trends of the industry, and provide data support and reference for policy improvement, industrial upgrading, and the healthy development of the intelligent cutting-edge medical industry in this field. Methods Taking the domestic and imported medical device registration information before March 31, 2025, from the Medical Device Data Query Platform of the National Medical Products Administration as the data source, six key fields including “navigation and positioning” and “endoscope” were screened to obtain the registration information of medical robot products. The included registration data of medical robot products were analyzed from six dimensions: registration quantity, product type, registration category, registrant situation, product composition, and intended use. Results As of the first quarter of 2025, the total number of registered medical robot products in China reached 135. The number of registrations has surged since 2021, with 44 registrations in 2024. In terms of product types, surgical robots dominated (88.15%), among which navigation and positioning products accounted for 71.11%, and rehabilitation robots accounted for 11.85%. In terms of registration categories, domestic products accounted for 93.33%, with most surgical robots being Class Ⅲ medical devices and all rehabilitation robots being Class Ⅱ medical devices. Registrants were mainly concentrated in the Yangtze River Delta, Beijing-Tianjin-Hebei, and Pearl River Delta regions. Only 20.74% of the product compositions clearly indicated the inclusion of software, and “robotic arm” was a frequently mentioned component. In terms of intended use, surgical robots were mainly applied in departments such as orthopedics and stomatology, while rehabilitation robots were primarily used for rehabilitation training of patients with lower limb motor dysfunction, and the intended use of various products reflected their core technical characteristics. Conclusion China’s medical robot industry is in a critical stage of technological innovation and market expansion. The number of product registrations will continue to grow, and the integration with new technologies will drive the diversification of product types and the expansion of application scenarios. However, the industry is also faced with problems such as non-standard product naming, increased difficulty in quality evaluation, uneven regional distribution of technologies, and lack of regulatory standards. In the future, it is necessary to improve the regulatory framework for medical robots, standardize naming rules, and fill the gaps in evaluation standards and methods to promote the healthy development of the industry.